This LEI Investigator Initiated Study aims to answer a critical question in the management of Diabetic Macular Oedema by testing regularly with conventional and novel ophthalmic imaging to predict early response to anti-vascular endothelial growth factor (VEGF) therapy.
Principal Investigator – Dr. Chandra Balaratnasingam
For more information please contact the Clinical Trials Office on (08) 9381 0750 or email clinicalresearch@lei.org.au
